BackFulgent Genetics Overview
Fulgent Genetics Inc

Fulgent Genetics Target Price

See Fulgent Genetics's analyst price targets ($19) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.65

Average Target Price

$19.008% downside

1 analysts in the last 4 months

High: $19 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Piper SandlerDavid Westenberg$198% downsideOpen
2026-05-05Piper Sandler$1527.4% downsideOpen
2025-11-14Raymond JamesAndrew Cooper$3674.3% upsideOpen
2025-08-05UBS$3045.3% upsideOpen
2025-08-04Piper Sandler$211.7% upsideOpen
2025-05-05Raymond JamesAndrew Cooper$2521.1% upsideOpen
2022-12-08Piper Sandler$4093.7% upsideOpen
2022-11-18Raymond James$45117.9% upsideOpen
2022-11-14Credit Suisse$50142.1% upsideOpen
2022-05-15Piper SandlerDavid Westenberg$70239% upsideOpen

Fulgent Genetics (FLGT) FAQ

Fulgent Genetics posts a target price of $19. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $19 for FLGT means covering analysts, on average, see the stock 8.0% downside of $20.65 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for FLGT's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Fulgent Genetics's other metric pages and overview cover the third.

Judging Fulgent Genetics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $19 here, then scan peer and history charts to see if the gap is persistent.